Top winners
| Symbol | Company Name | Price | Change | Change % |
| PRCT | Procept BioRobotics Corporation | 91.00 | +22.23 | +32.33% |
| OK | Oklo Inc. | 24.50 | +5.39 | +28.21% |
| DJTWW | Trump Media & technology Group Corp. | 8.73 | +1.55 | +21.59% |
| DJT | Trump Media & technology Group Corp. | 47.36 | +8.41 | +21.59% |
| NBIS | Nebius NV Group | 23.75 | +4.18 | +21.36% |
Main losers
| Symbol | Company Name | Price | Change | Change % |
| P.H.G. | Royal Philips N.V. | 26.62 | -5.05 | -15.95% |
| C.x. | Cemex, SAB de CV | 5.46 | -0.52 | -8.70% |
| NYCB | Flagstar Finance | 10.55 | -0.95 | -8.26% |
| Q.S. | QuantumScale Corporation | 5.69 | -0.50 | -8.08% |
| ADD | Adt Inc. | 7.37 | -0.51 | -6.47% |
In the trading session on October 28, the market opened with a gap, indicating bullish momentum as the rally continued in the first 15 minutes. Subsequently, the market completely deviated with small oscillations.
- New York Stock Exchange Composite: +93.4 (-0.48%)
- Dow Jones: +273.17 (-0.65%)
- S&P 500: +15.40 (+0.27%)
Winner #1: PRCT Stock
On October 28, Procept BioRobotics Corporation (NASDAQ: PRCT) stock hit a new high of $91.24 during the trading session. The company's value has skyrocketed by 237.14% in just one year. With constant progress and innovation in the medical sector, the company has successfully delivered on its promises, earning the trust of investors.
The FDA greenlit a pivotal trial in prostate cancer, comparing aquablation therapy to traditional radical prostatectomy. Based on current development, the company expects $50 million in annual revenue starting in 2026, as the company has started to see a significant 61% increase in total profits by the second quarter of 2024, reaching $53.4 million dollars. The FDA also approved ai-integrated treatment planning and advanced image guidance.
Technical analysis
PRCT/USD 15-Minute Stock Chart
Fundamentally, the stock has a lot of strength to rise; If we look at the technicals, we can see that the stock gained a whopping 32.33% return in a single day. The stock maintained a daily uptrend for a long time, indicating the strength of the buying.
Yesterday, the stock gapped and continued to rise, pushing the RSI into the overbought zone. Looking for an entry at the current price can be difficult as the stock has reached an all-time high with a large gap up, and if we look at historical data, we can see price reversals from a higher level when the RSI rises. in the overbought zone, as shown in the image. In this situation, there are two entry points.
- This can be a high risk and high reward trade. Using the Fibonacci retracement tool from the high of October 28 to the low of October 25, we can plan an entry if the price faces a rejection from the 0.5 level with the stop loss below the buy candle and a target of an all-time high. As the stock appears in the news, a rally from this level could occur.
- This trade can give you a low risk, high reward ratio as the price moves up while forming a trend line and swing. If the price retests the support trend line, then an entry can be made with a stop loss below the trend line and the all-time high target.
Loser #1: PHG Stock
Koninklijke Philips NV (NASDAQ: PHG) The stock plummeted 15% in the trading session on October 28. As demand from China deteriorates, Dutch cuts its sales outlook for 2024. The company recently published its Third quarter resultthat did not meet expectations. The Philips CEO said that while there is a drop in demand from China, they see growth in other regions.
There is a huge shortage of demand from hospitals and consumers in China, resulting in third-quarter sales of €4.38 billion, down from last year's €4.47 billion. of euros.
Investors seem disappointed by the chain's low revenue and demand, resulting in huge sales.
PHG/USD 15-minute chart
If we look at the chart on a daily time frame, we can see that the price has corrected by 15.95% in a single day. The price was in an uptrend for a long time, supporting the trend line and creating a rising wedge pattern at the same time. Still, on the trading session on October 28, the price broke the trend line on the trading session on October 25 and continued its downward rally consecutively on the second day.
Currently, the price is a channel and making an entry based on FOMO can result in losing money as the RSI is now in an oversold zone. There are two configurations in which sellers can position themselves.
- If the price retests the $27.98 level and suffers rejection, then one can enter with a target of $25.06 and a stop loss of $29.50.
- On the other hand, if prices continue to fall and break the $25.09 level, then entry can be made once the price retests the same level with the final target of $20.82 and a stop loss of $27.
!function (f, b, e, v, n, t, s) {
if (f.fbq) return;
n = f.fbq = function () {
n.callMethod ?
n.callMethod.apply(n, arguments) : n.queue.push(arguments)
};
if (!f._fbq) f._fbq = n;
n.push = n;
n.loaded = !0;
n.version = ‘2.0’;
n.queue = ();
t = b.createElement(e);
t.async = !0;
t.src = v;
s = b.getElementsByTagName(e)(0);
s.parentNode.insertBefore(t, s)
}(window, document, ‘script’,
‘https://connect.facebook.net/en_US/fbevents.js’);
fbq(‘init’, ‘504526293689977’);
fbq(‘track’, ‘PageView’);
